CTF1 and Hepatic steatosis: Although CT-1 was reported to be upregulated in human and murine steatotic livers and, chronic CT-1 treatment to reverse hepatic steatosis in obese mice after AMPK activation [25], we could not detect any involvement of the three SNPs in intrahepatic lipid content.